Chiome Bioscience leverages cutting-edge antibody technology for drug discovery and development| Shigeru Kobayashi,CEO, Chiome Bioscience Inc. 00:10:00
Revolutionizing antibody development with innovative technology, Chiome Bioscience accelerates drug discovery while pursuing sustainability and market growth through clinical trials and strategic partnerships.